Pseudomonas aeruginosa is an opportunistic pathogen that is a major cause of mortality in cystic fibrosis (CF) patients. This bacterium has numerous genes controlled by cell to cell signaling, which occurs through a complex circuitry of interconnected regulatory systems. One of the signals is the Pseudomonas Quinolone Signal (PQS), which was identified as 2-heptyl-3-hydroxy-4-quinolone. This intercellular signal controls the expression of multiple virulence factors and is required for virulence in an insect model of P. aeruginosa infection. Previous studies have implied that the intercellular signals of P. aeruginosa are important for human disease, and our goal was to determine whether PQS was produced during human infections. In this report, three types of samples from CF patients infected with P. aeruginosa were analyzed for the presence of PQS. Sputum, bronchoalveolar lavage fluid, and mucopurulent fluid from distal airways of end-stage lungs removed at transplant, all contained PQS, indicating that this cell to cell signal is produced in vivo by P. aeruginosa infecting the lungs of CF patients.
Introduction
Pseudomonas aeruginosa is an opportunistic pathogen which is a major source of nosocomial infections and lung infections in cystic ¢brosis (CF) patients [1] . Due to poor pulmonary clearance, P. aeruginosa infects the lungs of the vast majority of CF patients at a young age [2, 3] . These infections are di⁄cult to treat and persist for the life of the patient, causing progressive lung damage that eventually leads to respiratory failure [4] . The ability of P. aeruginosa to rapidly develop antibiotic resistance, and its tragic consequences with regard to CF and other infections, has been a driving force in the search for novel therapeutic targets, such as the intercellular signals and their synthetic pathways [1, 5] .
Bacterial cell to cell signaling has been recognized as a vital activity for the virulence of numerous pathogenic bacteria, including P. aeruginosa [6] . P. aeruginosa produces at least three cell to cell signals which are part of a 'quorum sensing hierarchy' that controls an estimated 35 % of P. aeruginosa genes [7, 8] . This organism generates two major cell to cell signals which are members of the acyl-homoserine lactone signal family [N-(3-oxododecanoyl)-L-homoserine lactone (3-oxo-C 12 -HSL) and N-butyryl-L-homoserine lactone (C 4 -HSL)], and a unique third signal referred to as the Pseudomonas Quinolone Signal (PQS) [9, 10, 11] . PQS has been shown to induce the expression of the virulence factor elastase and rhlI, which encodes the C 4 -HSL synthase [9, 12] . To date, PQS is the only quinolone compound known to act as a cell to cell signal. Although the role of this signal in the pathogenesis of human infections is not known, it is necessary for P. aeruginosa virulence in a nematode killing assay [13] . It is also important to note that PQS signaling is regulated di¡er-ently from acyl-homoserine lactone signaling. Whereas acyl-homoserine lactone signals are produced at a time of rapid population growth, PQS is produced maximally in the late stationary phase of growth [12] . This suggests that PQS signaling is important when P. aeruginosa cells are under stressful conditions, such as those which would occur during a chronic infection in the lungs of CF patients.
The signaling systems of P. aeruginosa have been shown to be necessary for virulence in multiple models of infection [6] . Recent reports have demonstrated that acyl-homoserine lactone signaling can occur in vivo in the mouse lung, and acyl-homoserine lactone signals are produced by P. aeruginosa growing 'ex vivo' within sputum samples from infected CF patients [14, 15] . In this report, we present data which show that PQS was present in three di¡erent types of samples from infected CF patients. These data provide strong evidence that PQS-mediated cell to cell signaling occurs within the infected CF lung and that PQS may be a unique drug target for the development of new therapies for treating P. aeruginosa infections.
Materials and methods

Sample and strain collection
All CF patient samples were collected at the Cystic Fibrosis/Pulmonary Research and Treatment Center at The University of North Carolina following an Internal Review Board approved protocol that adheres to all federal and institutional requirements for informed consent and con¢dentiality. All P. aeruginosa cultured from CF patients, except for strains CF824004 and CF713001, was obtained from the University of North Carolina Hospital Clinical Microbiology Laboratory. Pure cultures of strains CF824004 and CF713001 were isolated by plating an aliquot of bronchoalveolar lavage £uid (BALF) from samples 824004 and 713001 onto Bacto Pseudomonas Isolation Agar (Difco Laboratories, Detroit, MI, USA). P. aeruginosa strain PAO1 (wild-type) and PAO-JP2 (lasI, rhlI) have been described previously [16, 17] . All strains were stored at 380 ‡C in 10% skim milk [10] . The relative density of P. aeruginosa in each sputum sample was determined at the University of North Carolina Hospital Clinical Microbiology Laboratory by a dilution streak plate method. For this non-quantitative method of determining bacterial density, a grade of 0, 1+, 2+, 3+, or 4+ was assigned depending on the growth seen in each dilution streak on a plate (0 = no bacteria and 4 = bacteria present after four dilution streaks). The ¢nal P. aeruginosa density grade assigned to each sputum sample was the sum of the density grades for each di¡erent identi¢able strain of P. aeruginosa. It should be noted here that sputum samples 241601, 341701, 442301, and 642801 contained at least two di¡erent strains of P. aeruginosa (based on colony phenotype) and therefore received grades higher than 4+. Sputum was stored at 380 ‡C until analysis for PQS content. BALF samples were obtained by lavage with sterile 0.9% NaCl and stored at 380 ‡C before analysis. The presence of P. aeruginosa in BALF samples was determined at the University of North Carolina Hospital Clinical Microbiology Laboratory by plate culture of aliquots from each sample. Mucopurulent lung £uid was obtained from the airways of a lung that had been removed from a transplant patient who was chronically infected by P. aeruginosa. A 1 ml syringe was used to collect approximately 1 ml of mucopurulent airway £uid which was then stored at 380 ‡C before analysis.
Extraction of PQS from bacterial cultures
Bacteria from frozen stocks were grown overnight on PTSB [18] agar plates at 37 ‡C. Isolated colonies were used to inoculate 10 ml of PTSB which was then incubated for 18 h at 37 ‡C with vigorous shaking. Cultures were diluted 1:100 into fresh media and grown for 24 h as above. A 400 Wl aliquot of each culture was mixed with 800 Wl of acidi¢ed ethyl acetate [9] , vortexed vigorously for 30 s, then centrifuged for 10 min at 16 000Ug. The organic phase was transferred to a fresh tube, and the aqueous phase was re-extracted with an additional 800 Wl of solvent. The organic phases were combined, dried to completion and the solute was dissolved in 200 Wl of a 1:1 mix of acidi¢ed ethyl acetate:acetonitrile for analysis.
Thin layer chromatography (TLC)
TLC was performed with a silica gel 60 F 254 TLC plate (EM Science, Gibbstown, NJ, USA) that had been soaked in 5% KH 2 PO 4 and activated at 100 ‡C for 1 h. Extracts were separated with the use of 17:2:1 methylene chloride:acetonitrile :dioxane as the solvent. When the solvent front reached the top of the plate, the plate was illuminated with UV light and photographed. Synthetic PQS used for controls on TLC plates has been described previously [9] .
Extraction of PQS from body £uids
For sputum, a 400 Wl aliquot of sputum was mixed with 300 Wl of 0.9% NaCl, vortexed vigorously, and then extracted twice with 700 Wl of acidi¢ed ethyl acetate as described above. The organic phase was dried, dissolved in 20 Wl of a 1:1 mix of acidi¢ed ethyl acetate:acetonitrile, and the entire sample was loaded onto a TLC plate which was analyzed as described above. For BALF, a 200 Wl aliquot of each BALF sample was extracted with 800 Wl of acidi¢ed ethyl acetate and the entire sample was analyzed by TLC as described above. For mucopurulent airway £uid, approximately 1 ml of airway £uid was mixed with 1 ml 0.9% saline, vortexed vigorously, and extracted twice with 2 ml acidi¢ed ethyl acetate as described above.
The resultant solutes were dissolved in 60 Wl of a 1:1 mix of acidi¢ed ethyl acetate:acetonitrile and the sample was centrifuged at 16 000Ug for 5 min at room temperature. The entire supernatant was then loaded onto a TLC plate and analyzed as described above.
Results
PQS production by P. aeruginosa cultured from chronically infected CF patients
Our goal was to determine whether P. aeruginosa living within the CF lung produced the intercellular signal PQS. To begin to explore this idea, several P. aeruginosa isolates that were cultured from CF patients were assayed for the ability to produce PQS in vitro. Culture supernatants were extracted with acidi¢ed ethyl acetate and extracts were separated by TLC. Under our solvent conditions, PQS £uoresces blue under ultraviolet light and can be isolated and distinguished from other P. aeruginosa secreted organic molecules (SOMs) found in culture extracts [9] . For the current study, we analyzed a set of 10 strains cultured from di¡erent patients and found that nine of the 10 produced varying amounts of PQS (Fig. 1) . Seven of the CF strains and the prototype strain PAO1 also produced an unidenti¢ed SOM (Compound B), which £uoresced orange under ultraviolet light and had a slightly higher R f value than PQS. One strain, CF1042, had a SOM pro¢le similar to the control strain PAO-JP2 (lasI, rhlI), which did not produce detectable amounts of PQS or Compound B. These results led us to conclude that many P. aeruginosa CF strains are capable of producing PQS when grown in vitro. Fig. 1 . TLC analysis of P. aeruginosa cultured from CF patients. Cultures of P. aeruginosa strains derived from CF patients were subjected to organic extraction and analyzed by TLC as described in Section 2. An amount of extract derived from 5 Wl of culture was loaded onto the TLC plate. PQS is indicated by an arrowhead. Compound B is the spot directly above PQS in some lanes (lane 2, for example). This experiment was repeated more than three times and the resulting photograph is representative of all experiments. The lanes were loaded as follows: Lane 1, 125 ng synthetic PQS; 2, strain PAO1; 3, strain PAO-JP2; 4, strain CF1119 ; 5, strain CF1167 ; 6, strain CF50876 ; 7, strain CF8776 ; 8, strain CF61636; 9, strain CF1204 ; 10, strain CF863 ; 11, strain CF1042; 12, strain CF824004; 13, strain CF713001; 14, 62.5 ng synthetic PQS; 15, 30 ng synthetic PQS; 16, 15 ng synthetic PQS. Fig. 2 . Analysis of sputum samples from CF patients infected with P. aeruginosa. A 400 Wl aliquot of sputum was subjected to organic extraction and analyzed by TLC as described in Section 2. The relative density of P. aeruginosa in each sputum sample is indicated above each lane. PQS is indicated by an arrowhead. The lanes were loaded as follows: Lane 1, 150 ng synthetic PQS; 2, sputum sample 141801; 3, sputum sample 241601; 4, sputum sample 341701; 5, sputum sample 442301; 6, sputum sample 542701; 7, sputum sample 642801; 8, sputum sample 742801; 9, sputum sample from uninfected volunteer.
PQS in the sputum of infected CF patients
We then analyzed sputum from seven infected CF patients and an uninfected, non-CF volunteer. Sputum samples from four infected individuals exhibited both PQS and Compound B (Fig. 2, lanes 3, 4, 5, and 7) , which indicated that PQS is produced in vivo. Two sputum samples displayed Compound B and no PQS (Fig. 2, lanes 2  and 6) , and one CF sputum sample was similar to sputum from the uninfected volunteer, which contained no apparent P. aeruginosa SOMs (Fig. 2, lanes 8 and 9) . It is interesting to note that the amount of PQS evident in each extract correlates with the relative density of P. aeruginosa in each sample. The largest amount of PQS was recovered from sputum sample 642801 (Fig. 2, lane 7) . When the PQS in sample 642801 was compared densitometrically to a set of PQS standards (data not shown), it was estimated that the concentration of PQS in the sputum from this patient was 2 WM. This concentration is on the edge of the physiologically active range, but we must assume that this is an underestimate of the actual amount because of the ine⁄cient PQS recovery achieved by organic extraction [9] .
Examination of BALF and mucopurulent airway £uid from CF patients
Since sputum must pass through the oral cavity and consists of a mixture of lower and upper respiratory tract secretions, we also examined samples collected below the larynx. First, we tested BALF from four CF patients. Two of the patients were infected with only P. aeruginosa and the other two patients were infected with only Haemophilus in£uenzae. The results showed that PQS was present in the BALF samples from both patients infected by P. aeruginosa (Fig. 3) . In addition, Compound B was also present in the BALF from one of these patients (Fig. 3A, lane 3) . The BALF control samples from the patients infected with only H. in£uenzae contained no PQS or Compound B (Fig. 3) . These data indicate that PQS was produced by P. aeruginosa in the bronchoalveolar space of CF patients. We also analyzed mucopurulent airway secretions that were collected from two di¡erent sites within a freshly resected lung of a chronically infected CF patient who was a transplant recipient. Microscopic examination of mucopurulent airway £uid such as this has shown that bacterial macrocolonies/bio¢lms are randomly dispersed in this £uid [19] . The results presented here show that both samples contained PQS and Compound B (Fig. 4) , which provides additional evidence that PQS is produced inside the CF lung.
Discussion
Our ¢ndings indicate that each type of CF sample tested contained the cell to cell signal, PQS. Most interestingly, the amount of PQS present in sputum samples, which are relatively simple to collect, correlated directly with the estimated density of P. aeruginosa in the sample. We also found that at least one other P. aeruginosa SOM (Compound B) was present in some samples, causing us to speculate that SOMs may some day be useful as markers that could help di¡erentiate individual infections with regard to aspects such as the degree of pathogenicity of a particular strain and/or the infectious stage that has developed.
The importance of bacterial cell to cell signaling in virulence has been well documented [6] . However, the demonstration of in vivo cell to cell signaling within a human host has been elusive. In an innovative experiment, Wu et al. [15] showed that intercellular signaling between bacteria can occur in the lungs of infected mice. They co-infected mice with a signal-bioassay strain and a signal-producing strain and saw that signaling occurred in the mouse lung [15] . Others have since shown that P. aeruginosa-infected CF sputum, which was incubated after collection, contained both 3-oxo-C 12 -HSL and C 4 -HSL [14] . Interestingly, the ratio of these two signals suggested that P. aeruginosa living within sputum was growing as a bio¢lm [14] . Most recently, exciting reports by Erickson et al. [20] and Middleton et al. [21] suggested that a mixture of acyl-homoserine lactone signals (including 3-oxo-C 12 -HSL and C 4 -HSL) was present in sputum samples collected from multiple patients infected with P. aeruginosa. It was also determined by chemical analysis that N-hexanoyl-L-homoserine lactone (C 6 -HSL) was present in a pool of numerous sputum samples from one patient [21] . The signi¢-cance of this minor signal being the only detectable signal in the sputum is not clear, but suggests that in vivo and in vitro signaling by P. aeruginosa may be quite di¡erent. Our data provide further proof that cell to cell signaling occurs when P. aeruginosa has infected the CF lung.
As P. aeruginosa sets up a chronic infection in the CF lung, it obviously utilizes numerous factors that allow for its survival. The demonstration of PQS in the CF lung leads us to speculate that this signal may be one of the factors that is important for the development and/or maintenance of the chronic infection state. The mechanism for this has yet to be determined, but the fact that PQS was found in all three types of samples tested suggests that the in vivo production of this compound may bene¢t P. aeruginosa in the lungs of CF patients. One ¢nal observation from our studies indicated that the concentration of PQS in the sputum sample which contained the highest amount of PQS was approximately 2 WM. This result, accompanied by the fact that PQS was seen even in liquid as dilute as BALF, suggested that a physiologically signi¢cant amount of this signal was being produced in the lung.
As we peer deeper into the bacterial world, the ability of these unicellular organisms to communicate with each other has become a fascinating aspect of their life. PQS is a unique intercellular signal that is produced by an important opportunistic human pathogen. This signal has been shown to be required for virulence in an insect model of infection [13] . In addition, the use of a PQS precursor analog was found to interfere with PQS synthesis and inhibit the production of elastase, a PQS-controlled virulence factor [5] . In the current work, we demonstrated that PQS was produced in the CF lung. The ¢ndings presented here are a key step in the study of intercellular signaling and its role in pathogenesis. This important information on the activity of P. aeruginosa residing within the lung makes it clear that the targeting of bacterial cell to cell signaling for the purpose of altering infection outcomes is a promising avenue of exploration.
